— Know what they know.
Not Investment Advice

AFFY OTC

Affymax, Inc.
1W: -20.0% 1M: +0.0% 3M: +23.1% YTD: +100.0% 1Y: +77.8% 3Y: -61.0% 5Y: -97.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $59984 mcap · 37M float · 0.0085% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$1M -98.5% ▼
5Y CAGR: -56.0%
Gross Profit
$1M -97.3% ▼
5Y CAGR: -56.1%
Operating Income
-$15M +83.7% ▲
Net Income
-$14M +84.6% ▲
EPS (Diluted)
$-0.39 +84.8% ▲
EBITDA
-$14M +84.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2009FY2010FY2011FY2012FY2013
Revenue$115M$113M$48M$94M$1M
YoY Growth+38.7%-2.1%-57.6%+97.8%-98.5%
Cost of Revenue$0$0$0$45M$12K
Gross Profit$115M$113M$48M$49M$1M
Gross Margin100.0%100.0%100.0%52.4%99.1%
R&D Expenses$157M$94M$76M$52M$12M
SG&A Expenses$37M$33M$33M$90M$28M
Operating Expenses$194M$127M$109M$141M$39M
Operating Income-$79M-$14M-$61M-$92M-$15M
Operating Margin-68.7%-12.8%-128.7%-97.5%-1099.1%
Interest Expense$105K$140K$144K$1M$2M
Income Before Tax-$78M-$14M-$61M-$93M-$17M
Tax Expense-$1M$1K$1K-$26K-$2M
Net Income-$77M-$14M-$61M-$93M-$14M
Net Margin-66.6%-12.5%-128.6%-99.0%-1053.6%
EPS (Diluted)$-4.06$-0.57$-1.84$-2.57$-0.39
EBITDA-$76M-$12M-$59M-$90M-$14M
Shares Outstanding19M24M33M36M37M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms